Webinar: Challenges in NASH Clinical Trials

When:  May 19, 2021 from 11:00 AM to 12:00 PM (ET)

Content Contributor

Nonalcoholic Fatty Liver Diseases SIG


  • Naim Alkhouri, MD
  • Manal F. Abdelmalek, MD, MPH, FAASLD
  • Mazen Noureddin, MD


  • Vlad Ratziu, MD


Join the Nonalcoholic Fatty Liver Disease Special Interest Group in discussing the current challenges in histological assessment in NASH clinical trials. Presenters will also discuss how to implement hard outcomes in NASH clinical trials and the use non-invasive biomarkers as primary endpoints for drug approval.